311 related articles for article (PubMed ID: 18642013)
1. Successful pregnancy outcome with 5-flurouracil, epirubicin, cyclophosphamide chemotherapy, and hemostatic radiotherapy with abdominal shielding for metastatic invasive intraductal breast carcinoma.
Sharma JB; Pushparaj M; Kumar S; Roy KK; Raina V; Malhotra N
Arch Gynecol Obstet; 2009 Mar; 279(3):415-7. PubMed ID: 18642013
[TBL] [Abstract][Full Text] [Related]
2. [Breast carcinoma and pregnancy. A case report].
Serrano Migallón JA; Sandoval Guerrero F; Miranda Hernández H; de la Garza Navarro JM
Ginecol Obstet Mex; 1988 Oct; 56():281-4. PubMed ID: 2856450
[No Abstract] [Full Text] [Related]
3. Combined chemotherapy and radiotherapy during conception and first two trimesters of gestation in a woman with metastatic breast cancer.
Andreadis C; Charalampidou M; Diamantopoulos N; Chouchos N; Mouratidou D
Gynecol Oncol; 2004 Oct; 95(1):252-5. PubMed ID: 15385141
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy for breast cancer during pregnancy: an 18-year experience from five London teaching hospitals.
Ring AE; Smith IE; Jones A; Shannon C; Galani E; Ellis PA
J Clin Oncol; 2005 Jun; 23(18):4192-7. PubMed ID: 15961766
[TBL] [Abstract][Full Text] [Related]
5. Fatal chemotherapy-induced encephalopathy following high-dose therapy for metastatic breast cancer: a case report and review of the literature.
Cossaart N; SantaCruz KS; Preston D; Johnson P; Skikne BS
Bone Marrow Transplant; 2003 Jan; 31(1):57-60. PubMed ID: 12621508
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy for breast cancer during pregnancy.
Mathelin C; Annane K; Dufour P; Liegeois P; Bergerat JP
Eur J Obstet Gynecol Reprod Biol; 2005 Dec; 123(2):260-2. PubMed ID: 16024158
[No Abstract] [Full Text] [Related]
7. Specific congenital malformations after exposure to cyclophosphamide, epirubicin and 5-fluorouracil during the first trimester of pregnancy.
Leyder M; Laubach M; Breugelmans M; Keymolen K; De Greve J; Foulon W
Gynecol Obstet Invest; 2011; 71(2):141-4. PubMed ID: 21160143
[TBL] [Abstract][Full Text] [Related]
8. Epirubicin for breast cancer during pregnancy: a case report.
Eedarapalli P; Biswas N; Coleman M
J Reprod Med; 2007 Aug; 52(8):730-2. PubMed ID: 17879836
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy with epirubicin and paclitaxel for breast cancer during pregnancy: case report and review of the literature.
Gadducci A; Cosio S; Fanucchi A; Nardini V; Roncella M; Conte PF; Genazzani AR
Anticancer Res; 2003; 23(6D):5225-9. PubMed ID: 14981994
[TBL] [Abstract][Full Text] [Related]
10. [Pneumo- and cardiotoxic side effects following combination chemotherapy with epirubicin and ifosfamide].
Franzen D; Pöhler E; Hilger HH
Med Klin (Munich); 1990 Mar; 85 Suppl 1():133-6, 170. PubMed ID: 2160577
[No Abstract] [Full Text] [Related]
11. Multimodal cancer therapy for breast cancer in the first trimester of pregnancy. A case report.
Murray CL; Reichert JA; Anderson J; Twiggs LB
JAMA; 1984 Nov; 252(18):2607-8. PubMed ID: 6092731
[No Abstract] [Full Text] [Related]
12. Sclerotic and retracted supravenous hyperpigmentation associated with combination chemotherapy for metastatic breast carcinoma.
Chen GY; Lee JY; Chen WC
Br J Dermatol; 2005 Jun; 152(6):1383-5. PubMed ID: 15949026
[No Abstract] [Full Text] [Related]
13. Adriamycin and cyclophosphamide chemotherapy in advanced breast cancer in pregnancy.
Skrablin S; Banović V; Matković V
Eur J Obstet Gynecol Reprod Biol; 2007 Aug; 133(2):251-2. PubMed ID: 16860457
[No Abstract] [Full Text] [Related]
14. [Clinical and histologic effects of preoperative combination chemotherapy of breast cancer].
Wang ZY
Zhonghua Wai Ke Za Zhi; 1988 Nov; 26(11):648-50, 700. PubMed ID: 2855506
[No Abstract] [Full Text] [Related]
15. New insight into epirubicin cardiac toxicity: competing risks analysis of 1097 breast cancer patients.
Ryberg M; Nielsen D; Cortese G; Nielsen G; Skovsgaard T; Andersen PK
J Natl Cancer Inst; 2008 Aug; 100(15):1058-67. PubMed ID: 18664656
[TBL] [Abstract][Full Text] [Related]
16. Cytokinetic-based versus conventional chemotherapy in metastatic breast cancer: a randomized study.
Conte PF; Rubagotti A; Falcone A; Gardin G; Nicolin A; Pronzato P; Rosso R; Amadori D; Gentilini P; Sismondi P
Chemioterapia; 1987 Jun; 6(2 Suppl):712-3. PubMed ID: 3334664
[No Abstract] [Full Text] [Related]
17. [Possibilities of the cytological method in the determination of therapeutic pathomorphosis of breast cancer].
Sidorova NA; Volchenko NN; Saribekian EK
Sov Med; 1991; (11):15-8. PubMed ID: 1662831
[TBL] [Abstract][Full Text] [Related]
18. Neonatal effects of breast cancer chemotherapy administered during pregnancy.
Kerr JR
Pharmacotherapy; 2005 Mar; 25(3):438-41. PubMed ID: 15843292
[TBL] [Abstract][Full Text] [Related]
19. High total dose 5-fluorouracil treatment during pregnancy.
Dreicer R; Love RR
Wis Med J; 1991 Oct; 90(10):582-3. PubMed ID: 1771920
[TBL] [Abstract][Full Text] [Related]
20. Cis-platinum combination chemotherapy during pregnancy for advanced epithelial ovarian carcinoma.
Malfetano JH; Goldkrand JW
Obstet Gynecol; 1990 Mar; 75(3 Pt 2):545-7. PubMed ID: 2304734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
